Targeted NGS for liquid biopsy research
Archer REVEAL ctDNA™ assays enable 28-gene tumor mutation profiling from plasma by
using AMP™ targeted enrichment chemistry to detect ultra-low allele frequency variants
in circulating tumor DNA (ctDNA). One-day library preparation and user-friendly, in-house
analysis mean results in only 3 days.
Visit us at AMP 2016 to learn more.
Booth #403
archerdx.com
AMP Workshop Day - November 9
• Keeping it Real: NGS-based profiling of cfDNA for liquid biopsy research
• FusionPlex: The gold standard in NGS-based translocation assays
• Fusions, ITDs, and More: Advanced NGS applications to characterize
hematological malignancies
28
For research use only. Not for use in diagnostic procedures.